umu.sePublications
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Anaesthesiology.ORCID iD: 0000-0001-8598-9804
Show others and affiliations
2019 (English)In: Scandinavian Journal of Clinical and Laboratory Investigation, ISSN 0036-5513, E-ISSN 1502-7686Article in journal (Refereed) Epub ahead of print
Abstract [en]

Sepsis is the most frequent cause of death in the intensive care unit (ICU). A rapid and correct diagnosis and initiation of therapy is crucial for improving patient outcomes. The aim of this study was to compare the performance of calprotectin with the more widely used sepsis biomarker procalcitonin (PCT) in ICU patients. The performance of calprotectin and PCT as sepsis and prognostic markers for 30-d mortality was compared in a prospective, observational study in an eight-bed ICU. We investigated concentrations of the biomarkers in plasma collected at admission from all ICU patients admitted during a year (2012-2013, n = 271) together with simplified acute physiology 3 scores (SAPS3) and sequential organ failure assessment (SOFA) scores. The receiver operating characteristic (ROC) analysis showed a higher area under the curve (AUC) value for calprotectin (0.79) than for PCT (0.49) when used as a sepsis marker. The calprotectin concentrations at admission were higher in non-survivors than in survivors at day 30. In our study, calprotectin was superior to PCT for distinguishing between ICU patients with sepsis and non-sepsis patients. Calprotectin also had higher predictive ability regarding 30-d mortality.

Place, publisher, year, edition, pages
Taylor & Francis, 2019.
Keywords [en]
Calprotectin, procalcitonin, sepsis, intensive care, SAPS3, SOFA
National Category
Anesthesiology and Intensive Care Infectious Medicine
Identifiers
URN: urn:nbn:se:umu:diva-167094DOI: 10.1080/00365513.2019.1703216ISI: 000502497900001PubMedID: 31841042OAI: oai:DiVA.org:umu-167094DiVA, id: diva2:1384146
Available from: 2020-01-09 Created: 2020-01-09 Last updated: 2020-01-09

Open Access in DiVA

fulltext(1106 kB)7 downloads
File information
File name FULLTEXT01.pdfFile size 1106 kBChecksum SHA-512
40dfbb85b91074baf090d5b2cf0b4261d609574a9bd59a23b7b81a79359c1e720e8065259da4caad334138d3fe47403b481f0f302dad21c3080bf228f9faf29e
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Tydén, Jonas

Search in DiVA

By author/editor
Tydén, Jonas
By organisation
Anaesthesiology
In the same journal
Scandinavian Journal of Clinical and Laboratory Investigation
Anesthesiology and Intensive CareInfectious Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 7 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 6 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf